Skin Cancer/Melanoma
Neoadjuvant Melanoma Combo Improves RFS in Macroscopic Melanoma
BY GINA COLUMBUS
BRAF-Mutant Melanoma Field Continues to Move Forward
BY BRITTANY COTE
FDA Approves New Pembrolizumab Dosing Schedule
BY JASON M. BRODERICK
Surgery a Mainstay in Melanoma as New Treatments Emerge
BY ELLIE LEICK
T-Cell Therapies Are Promising in Melanoma, But Challenges Remain
BY JESSICA HERGERT
Surgery Is Becoming Individualized in Melanoma Treatment
BY JESSICA HERGERT
Dermatologic Adverse Events in Melanoma: What to Look Out For
BY BRITTANY COTE
Nurse Offers Advice on Discussing AEs With Patients
BY KATHLEEN MADDEN, MSN, RN, APHN, AOCNP, FNP-BC
Detecting and Managing irAEs in Melanoma Is Crucial
BY BRITTANY COTE
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.